跳至主要内容
临床试验/NCT06734975
NCT06734975招募中2 期

Effect of Intraoperative Superior Laryngeal Nerve Blocks on Patient Outcomes in Microdirect Laryngoscopy for Benign Vocal Fold Lesions: A Randomized Trial

Rutgers, The State University of New Jersey1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2025年7月11日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
招募中
入组人数
28
试验地点
1
主要终点
Postoperative pain

研究概览

简要总结

Patients undergoing surgery on their vocal cord will either receive a numbing injection to their throat or a saline injection during surgery. Symptoms such as how much coughing or pain patients have after surgery, as well as whether patient's voice gets better will be interrogated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is aged 18 years or older at time of consent
  • Patient has suspected or confirmed benign vocal fold lesion
  • Patient is planning to undergo direct laryngoscopy with excision of the vocal fold lesion
  • Patient is English or Spanish speaking
  • Patient is not pregnant per self report
  • Patient is not incarcerated

排除标准

  • Patient is not 18 years of age or older at consent date
  • Patient does not speak English or Spanish
  • Patient is currently pregnant or plans to become pregnant prior to their study procedure
  • Patient has a laryngeal malignancy or found to find a laryngeal malignancy on final pathology
  • Patient will not be undergoing direct laryngoscopy with excision of lesion
  • Patient is unable to provide consent or complete study activities
  • Patient is incarcerated

研究组 & 干预措施

Superior laryngeal nerve block

Experimental

Patients will receive a superior laryngeal nerve block consisting of 1 milliliter of 0.25% bupivacaine and milliliter of triamcinolone acetate 40 mg/ml to the neck on the side of the vocal cord lesion during their surgery.

干预措施: Superior laryngeal nerve block - Intervention (Bupivacaine and triamcinolone acetonide suspension) (Drug)

Placebo

Placebo Comparator

Patients will receive a placebo of 2 milliliter saline injection to the neck on the side of the vocal cord lesion during their surgery.

干预措施: Superior laryngeal nerve block - Placebo (saline) (Drug)

结局指标

主要结局

Postoperative pain

时间窗: 1, 3 and 7 days after surgery

We will record postoperative pain via the 100 mm visual analog scale (VAS). The minimum is 0, maximum is 100, and a higher score indicates more pain and thus a worse outcome.

Postoperative cough

时间窗: Follow up appointment 2-4 weeks after surgery

Cough severity index score. The Cough Severity Index (CSI) is a validated 10 question survey about cough severity with each question rated on a Likert Scale from 0-4, where 4 is most severe. The maximum score is 40 and the minimum score is 0, where 40 represents the most severe cough.

Postoperative voice outcome

时间窗: Postoperative appointment 2-4 weeks after surgery

Voice Handicap Index-10 (VHI-10) score. The VHI-10 is a validated 10 question survey about quality of life related to dysphonia with each question rated on a Likert Scale from 0-4, where 4 is most severe. The maximum score is 40 and the minimum score is 0, where 40 represents the most vocal handicap.

次要结局

  • Post-extubation cough(5 minutes postoperative)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kenneth Yan, MD, PhD

Assistant Professor, Laryngology

Rutgers, The State University of New Jersey

研究点 (1)

Loading locations...

相似试验